As of last Q it’s 20% from TSP and 80% from evok.
Evok was launched in late 2022. So it’s not even 2 years and this is the contribution. It’s doesn’t take P.HD level math to understand that the near/medium prospects of company are tied to evok/cosmos angle.
They may say whatever on the number of products in pipeline and ready for launch But market may lookout for the prospects of evok ?
Evok topline was linked to transaction value/volume and hence it was easier to show super growth. TSP topline isn’t linked to transaction volume but to number of clients. So the growth was dwarfed by evok. iMHO the million dollar question is, which of future products can have characteristics similar to evok in terms of growth possibility.
| Subscribe To Our Free Newsletter |
